In the comparative analysis conducted over the follow-up period (6 months, 12 months, 18 months, and 24 months), the values of adipokines (adiponectin, resistin, and the AR index) significantly differed between T2DM participants with and without MetS at all measurement points (Table S1). This evidence concerns the gene RETN and metabolic syndrome.